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Polycystic ovary syndromeAbstract Background: Reproductive, clinical and laboratory implication varies in polycystic
ovary syndrome (PCOS) according to body weight.
Objective: To compare reproductive, clinical and laboratory data between obese and non obese
women with PCOS.
Methods: A cohort of 180 women with PCOS who attended outpatient clinic of Taibah University
from January to September 2012 was included. Studied women were classiﬁed according to body
mass index (BMI) into overweight/obese (BMI >25 kg/m2) and normal weight women (BMI
625 kg/m2). Each participant answered a specially designed interviewing format and subjected to
medical checkup for signs of hyperandrogenism. Fasting insulin and glucose, follicle stimulating
hormone (FSH), luteinizing hormone (LH), estradiol (E2), prolactin (PRL), progesterone and tes-
tosterone levels were estimated. Statistical analyses were performed as appropriate.
Results: Of the studied 180 PCOS women, there were 80 overweight obese women (44.4%) and 100
normal weight women (55.6%). Obese PCOS women were less highly educated, less working and
reported low family history rate of PCOS. Compared to non obese PCOS women, obese PCOS
women reported higher age of menarche, abortion and menstrual disturbance with statistically sig-
niﬁcant difference. Signs of hyperandrogenism and ancanthosis nigricans were signiﬁcantly more
manifested in obese PCOS women. Mean levels of studied metabolic and sex hormones were signif-
icantly higher in obese PCOS women.
6 M.I. Mahmoud et al.Conclusions: Overweight and obese PCOS women had signiﬁcantly higher age of menarche, abor-
tion and menstrual disturbances. Also, signs of hyperandrogenism, acanthosis nigricans were more
encountered among them with higher levels of fasting glucose, fasting insulin, FSH, LH and testos-
terone.
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reserved.1. Introduction
Polycystic ovary syndrome (PCOS) is a fairly common disor-
der of women in reproductive age. It is characterized by hyper-
androgenism and chronic anovulation.1,2 It has a prevalence of
5–10% based upon studies which found that; 20% of self-se-
lected normal women had polycystic ovary morphology on
ovarian ultrasound. Many of these studied women had endo-
crine abnormalities.3 It was found that 75% of women with
secondary amenorrhea fulﬁlled diagnostic criteria for
PCOS.1,3–5 PCOS was the cause of 82% of hirsutism among
Saudi female population.6 The recent theories of the pathogen-
esis of polycystic ovary syndrome (PCOS) have focused on the
role of insulin resistance and hyperinsulinemia. Irrespective of
the pathogenic mechanisms involved, many women with
PCOS (between 38% and 88%) have been found to be over-
weight and obese, and the studies reported that obese PCOS
women have more severe hyperandrogenism and related clini-
cal features (such as hirsutism, menstrual abnormalities and
anovulation) than normal weight PCOS women.7 Even modest
weight loss of 5% body weight has been shown to result in sig-
niﬁcant improvements in both symptoms of hyperandrogenism
and ovulatory function in women with PCOS.8,9 There is no
doubt, therefore, that adiposity plays a crucial role not only
in the development but also in the maintenance of PCOS man-
ifestations and strongly inﬂuences the severity of both its clin-
ical and endocrine features in many women with the
condition.10 Despite these reported data, there is still a short-
age of studies, particularly in our region, that compare the
reproductive, clinical and laboratory data in obese and non
obese PCOS women. Therefore, this study was carried out to
clarify if there is a difference in reproductive, clinical and lab-
oratory parameters between obese and non obese patients with
PCOS.
2. Subjects and methods
The study was carried out on a cohort of women with PCOS
who attended the outpatient clinics at Taibah University, Fe-
male section from January to September 2012. All included
women (180 cases) were previously diagnosed to have PCOS
(depending on their ultrasound ﬁndings by presence of eight
or more subcapsular follicular cysts 610 mm and increased
ovarian stroma).2,3 All studied women were not pregnant nor
diabetic. The studied women were divided into two groups
based upon their BMI: obese PCOS patients (80 cases) with
BMI P25 kg/m2 and non obese patients PCOS (100 cases)
with BMI <25 kg/m2) (100 cases).
Every participant woman was interviewed and asked to
answer a specially designed interviewing format including;
socio-demographic data, menstrual, gynecological, obstetric,
medical and family histories. Oligomenorrhea was consideredwhen menses ﬂow every 6 weeks to 6 months.2,4,5 She was also
subjected to medical checkup for signs of hyperandrogenism
and polycystic ovary. Anthropometric measurements including
weight, height (to calculate BMI), waist and hip measurements
(with calculation of waist to hip ratio (WHR)) were
performed.
The following laboratory tests were recommended for
each participant: fasting insulin level, fasting glucose level,
follicle stimulating hormone (FSH), luteinizing hormone
(LH), oestradiol (E2), progesterone, prolactin (PRL), and tes-
tosterone. All laboratory investigations were done in one of
the reference labs in Medina. The collected reproductive, clin-
ical and laboratory data were compared between the studied
two groups.
Approval of Research Ethics committee for Medical Col-
lege, Taibah University was considered and ofﬁcial permission
was assured. Before inclusion of any participant in this study,
an informed written signed consent was obtained after expla-
nation of the objective and methodology of the research. Also,
privacy and conﬁdentiality of the participants were assured.
The data were analyzed by using SPSS package version 17.
In order to compare the distribution of the studied factors in
obese and non obese PCOS women, v2 tests for the categorical
variables and t test for the continuous variables were used. The
level of statistical signiﬁcance was deﬁned as p 6 0.05.3. Results
Of the studied 180 PCOS women, there were 80 (44.4%)
overweight and obese women and 100 (55.6%) normal weight
women. The mean age of the studied women was
41.7 ± 6.8 years. Table 1 presents the general characteristics
of the studied obese and non obese PCOS women. The mean
age of obese PCOS women was higher than that of non obese
patients with statistically signiﬁcant difference (p= 0.002).
Obese women with highly educated level were signiﬁcantly
higher than highly educated non-obese women with PCOS
(57.5% compared to 72.0% where p= 0.023). The percent
of ever married women, however, was signiﬁcantly highly
(67.5%) encountered among obese women compared with
non obese patients (58.0%) (p= 0.030). Also, positive family
history of PCOS was signiﬁcantly higher among ﬁrst degree
relatives of obese patients (67.5%) compared with non obese
patients (52.0%) (p= 040).
Table 2 shows the reproductive and clinical characteristics
of obese and non obese women with PCOS. The mean age
of menarche among obese women was signiﬁcantly higher than
that of non obese women (16.3 ± 2.11 and 14.5 ± 3.24 respec-
tively; p= 0.02).
The mean number of reported abortion among non-obese
women with PCOS was insigniﬁcantly lower than that among
obese ones (0.9 ± 0.62 versus 1.3 ± 0.24).
Table 1 General characteristics of obese and non obese PCOS women.
Obese PCOS (n= 80) Non-Obese PCOS (n= 100) P value
n % n %
Basic education 41.7 ± 6.86 32.5 ± 8.94 0.002**
Education levela
Basic education 14 17.5 10 10.0
Secondary education 20 25.0 18 18.0 0.023**
High education 46 57.5 72 72.0
Work status
House wife 46 57.5 38 38.0 0.001**
Working 34 42.5 62 62.0
Marital status
Never married 26 32.5 42 42.0 0.030**
Ever married 54 67.5 58 58.0
Family history of PCOS
Yes 54 67.5 52 52.0
No 26 32.5 48 48.0 0.040**
a Basic education includes primary and preparatory level. High education includes University degree and more.
** Signiﬁcant.
Table 2 Reproductive and clinical characteristics of obese and non obese PCOS women. The bold values are total and the italic below
are subtotal.
Obese PCOS (n= 80) Non-obese PCOS (n= 100) P value
n % n %
Age of menarche (mean ± SD) 16.3 ± 2.11 14.5 ± 3.24 0.02**
Obstetric historya
Age at ﬁrst marriage 19.4 ± 3.62 21.8 ± 2.95 0.02**
Gravidity 2.3 ± 0.65 1.5 ± 0.34 0.060
Abortion 1.3 ± 0.24 0.9 ± 0.62 0.240
Parity 1.1 ± 0.21 0.8 ± 0.31 0.310
Menstrual disturbances
No disturbance 12 15.0 24 24.0 0.006**
With disturbance 86 85.0 76 76.0
Oligomenorrhea 46 67.7 42 55.3
Amenorrhea 18 26.5 22 28.9
Dysfunctional bleeding 4 5.8 12 15.8
Acromegalic features
Yes 22 27.5 26 26.0 0.080
No 58 72.5 74 74.0
Signs of hyperandrogenism
Yes 38 47.5 36 36.0 0.020**
No 42 52.5 64 64.0
Acanthosis nigricans
Yes 34 42.5 28 28.0 0.040**
No 46 57.5 72 72.0
a Analyses included 112 ever married women.
** Signiﬁcant.
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tered among whole studied women with PCOS (162 out of
180 representing 90%). When considering obesity, menstrual
disturbances were signiﬁcantly highly encountered in obese
women with PCOS (85%) particularly oligomenorrhea
(67.7%). Omit p= 0.006. Also, the signs of hyperandrogenism
and acanthosis nigricans were more signiﬁcantly observed
among obese PCOS women compared with non obese patients
(p= 0.020 and 0.040 respectively).Table 3 displays the biochemical data in the studied obese
and non-obese PCOS women. The mean values for most of
the studied biochemical parameters were signiﬁcantly higher
in obese PCOS patients than that for non-obese ones.
4. Discussion
Polycystic ovary syndrome is a common disorder of premeno-
pausal women characterized by hyperandrogenism and
Table 3 Biochemical data in obese and non obese PCOS
women.
Obese PCOS
(n= 80)
Non obese
PCOS (n= 100)
P value
Fasting glucose level
(mg/ml)
121.5 ± 5.9 114.8 ± 2.98 0.035**
Fasting insulin level
(pmol/ml)
61.5 ± 4.45 53.29 ± 75 0.041**
FSH level (mIU/ml) 5.4 ± 0.12 6.4 ± 1.22 0.048**
LH level (IU/ml) 6.7 ± 2.67 4.32 ± 1.93 0.036**
Progesterone level (ng/ml) 1.9 ± 0.76 1.7 ± 0.98 0.079
E2 (Pg/ml) 49.9 ± 5.85 48.5 ± 4.86 0.362
PRL (lg/ml) 24.9 ± 2.37 21.6 ± 5.65 0.069
Testosterone level (ng/dL) 110.7 ± 5.56 90.6 ± 8.65 0.009**
** Signiﬁcant.
8 M.I. Mahmoud et al.chronic anovulation.1,2 PCOS women are characterized by
being obese in 16–80% of cases.11–14 It is reported that PCOS
is accompanied by menstrual irregularity ranging from oligo-
menorrhea, amenorrhea, or dysfunctional uterine bleeding.2,4,5
The results of the present study appeared consistent with these
reports where menstrual irregularities were a complaint among
90% of studied PCOS women. Studying menstrual and obstet-
ric features showed a statistical signiﬁcant difference between
obese and non-obese women regarding the obstetric and men-
strual histories. Delayed age at menarche, oligomenorrhea and
abortion was manifested in obese women. It is well known that
obesity is associated with anovulation, pregnancy loss and late
pregnancy complications (pre-eclampsia, gestational diabe-
tes).8 Obesity in PCOS is also linked to failure or delayed re-
sponse to the various treatments including clomiphene
citrate, gonadotropins and laparoscopic ovarian diathermy.
It has been reported that, after losing as little as 5% of initial
body weight obese women with PCOS improved spontaneous
ovulation rates and spontaneous pregnancy.8,9
The present work showed a higher mean level of fasting
blood sugar and fasting insulin level among obese PCOS wo-
men. The same ﬁnding was also obtained from a recent hospi-
tal-based Saudi study where obesity in Saudi women was
associated with hyperinsulinaemia and insulin resistance.6
Since the report by Solomon Thomas et al.14 in 1980 that
PCOS was associated with hyperinsulinemia, it has become
clear that the syndrome has major metabolic as well as repro-
ductive morbidities.14 Insulin resistance, hyperinsulinemia, and
beta-cell dysfunction are very common in PCOS, but are not
required for diagnosis. It is an important defect in the patho-
genesis of noninsulin-dependent diabetes mellitus (NIDDM).15
It was proved that hyperinsulinemia in PCOS occurred inde-
pendent to the presence of obesity.16,17 Nevertheless, obese
PCOS had signiﬁcantly increased blood glucose levels in
20% of cases than control.17 The majority of affected women
are in their third and fourth decade of life19,20 which was con-
comitant with the results of the present study where the mean
age of the recruited women was 41.7 ± 6.8 years. These ﬁnd-
ings, together with the evidence obtained from previous re-
ports that a huge number of PCOS women show a condition
of insulin resistance and hyperinsulinemia, suggested that insu-
lin may play the basic role in the promotion and/or the main-
tenance of PCOS, particularly on obese women.
In the current study, acanthosis nigricans was detected in
42.5% of studied obese women compared to only 28% detectedin non obese one. Similar to these ﬁndings, mild to moderate
acanthosis nigricans has been reported to occur more in obese
PCOS women.15,18 Also, hyperandrogenism was found in
47.5% of studied obese cases. Obesity may also contribute to
features of hyperandrogenism even in women with normal ova-
ries.19 It plays a pivotal role in the promotion or the mainte-
nance of PCOS. Moreover, obesity seems to amplify the
degree of hyperandrogenism in PCOS. Previous studies have
shown that obese PCOS women have total and free testosterone
levels higher with respect to non-obese PCOS. Abdominal obes-
ity may also further worsen the hyperandrogenic state in PCOS
women.19,20 In the current study a higher mean testosterone le-
vel (110.7 ± 5.56) was detected in obese PCOS women.
As reported in a previous study that PCOS women may
occasionally have acromegaloid features,21 this study have
found about one-fourth of the studied women to have had
acromegalic features with no statistically signiﬁcant difference
between obese (27.5%) and non obese (26%.0%) PCOS
women.
Endocrinal changes have been compared in the present
study between obese and non obese PCOS women. FSH level
was low in the studied obese women, meanwhile prolactin was
high. Insigniﬁcant differences in the values of both estradiol
and progesterone between obese and non obese PCOS were
also detected. Increase of body weight and fat tissue in women
was associated with several abnormalities of sex hormone bal-
ance,22 and obesity per se represents a condition of functional
hormonal imbalance. FSH plays a central role in the control of
oogenesis, follicle development and gametogenesis.23,24 Dimin-
ished secretion of FSH in PCOS can result in failure of gona-
dal function (hypogonadism).23 This can also result from high
prolactin levels; which tends to suppress the ovulatory cycle by
inhibiting the secretion of FSH.25
As this study was performed in the outpatient clinics at Tai-
bah University, Female section, the generalization of its results
is difﬁcult. It is also important to realize that results which
come from one center may simply not be similar for other cen-
ters as differences in the socio-demographic characteristics of
patients attending such centers. However, and according to
our knowledge, this study is the ﬁrst in our region to compare
reproductive, clinical and laboratory data between obese and
non obese PCOS women.
In summary, obesity appeared to further increase the repro-
ductive, clinical and laboratory changes known to be associ-
ated with PCOS. Consequently, obese PCOS women tend to
be at more risk of menstrual irregularities and obstetric com-
plications. Also, signs of hyperandrogisism, acanthosis nigri-
cans with endocrinal and hormonal disturbances tend to be
more in obese than normal weight PCOS women. From these
points of view, weight reduction should be included as an adju-
vant tool in the management plan for obese PCOS.Conﬂict of interest
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